BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Global Biodefense - ECPv6.17.5.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://globalbiodefense.com
X-WR-CALDESC:Events for Global Biodefense
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20180311T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20181104T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20180311T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20181104T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20190310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20191103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190427
DTEND;VALUE=DATE:20190505
DTSTAMP:20240623T231022Z
CREATED:20190210T010840Z
LAST-MODIFIED:20240623T231022Z
UID:24740-1556323200-1557014399@globalbiodefense.com
SUMMARY:National Infant Immunization Week - NIIW 2019
DESCRIPTION:This year’s annual observation of National Infant Immunization Week is April 27-May 4\, 2019. \nNIIW highlights the importance of protecting infants from vaccine-preventable diseases and to celebrate the achievements of immunization programs and their partners in promoting healthy communities. \nThis is the 25th anniversary of NIIW. Since 1994\, hundreds of communities across the United States have joined to celebrate the critical role vaccination plays in protecting our children\, communities\, and public health. \nSeveral important milestones in controlling vaccine-preventable diseases among infants worldwide worldwide have already been reached: \n\nVaccines have drastically reduced infant death and disability caused by preventable diseases in the U.S.\nThrough immunization\, we can now protect infants and children from 14 vaccine-preventable diseases before age two\nRoutine childhood immunization in one birth cohort prevents an estimated 381 million illnesses\, 24.5 million hospitalizations\, and 855\,000 early deaths over the course of their lifetimes\, at a net savings of $360 billion in direct costs and $1.65 trillion in total societal costs\nThe National Immunization Survey has consistently shown that childhood immunization rates for vaccines routinely recommended for children remain at or near record levels\n\nOne example of the seriousness of vaccine preventable diseases is an increase in measles cases and outbreaks in the United States in recent years. \nNIIW provides an opportunity to: \n\nHighlight the dangers of vaccine-preventable diseases\, especially to infants and young children\, and the importance and benefits of childhood immunization\nEducate parents and caregivers about the importance of vaccination in protecting their children from birth against vaccine-preventable diseases\nFocus attention on immunization achievements and celebrate the accomplishments made possible through successful collaboration\nStep up efforts to protect children against vaccine-preventable diseases and thereby give them a healthy start in life\nEncourage better communication between parents and healthcare professionals.\nRemind parents and caregivers of the importance of making and keeping needed immunization appointments.\nProvide help to parents and caregivers to locate a healthcare professional who participates in the Vaccines for Children’s program\, a federally funded program that provides vaccinations at no cost to children whose parents cannot afford to pay for them.\n\nNIIW is celebrated as part of World Immunization Week (WIW)\, an initiative of the World Health Organization (WHO). During WIW\, all six WHO regions\, including more than 180 Member States\, territories\, and areas\, will simultaneously promote immunization\, advance equity in the use of vaccines and universal access to vaccination services\, and enable cooperation on cross-border immunization activities.
URL:https://globalbiodefense.com/event/national-infant-immunization-week-niiw-2019/
CATEGORIES:Awareness Event
ATTACH;FMTTYPE=image/png:https://globalbiodefense.com/wp-content/uploads/2019/02/national-infant-immunization-week-niiw.png
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190429
DTEND;VALUE=DATE:20190503
DTSTAMP:20190501T164018Z
CREATED:20190210T235136Z
LAST-MODIFIED:20190501T164018Z
UID:18348-1556496000-1556841599@globalbiodefense.com
SUMMARY:EIS 2019 - CDC Epidemic Intelligence Service Conference
DESCRIPTION:CDC’s 68th annual Epidemic Intelligence Service conference starts April 29. Join CDC disease detectives\, alumni\, and the public health community to learn about leading-edge public health investigations. \nThe annual EIS conference is the nation’s premier epidemiology conference where EIS officers share their work in leading-edge investigations\, scientific findings\, and forward-thinking strategies to inform improvements in public health—all while gaining valuable presentation experience. EIS officers engage in professional networking sessions\, recognition ceremonies and various learning opportunities. \nFree and open to the public\, this conference draws a diverse attention each year from various public health sectors around the world—from epidemiology and laboratory science sleuths and public health organizations to EIS alumni\, news media\, and prospective applicants. \nWhen a killer bacterium unleashes an outbreak on a beach town\, unlikely partners work to find the water source. Hear more about this and other topics in live streamed TED-style talks at the 68th Annual Epidemic Intelligence Service Conference. https://bit.ly/2Geb3CcExternal \nPlease visit the CDC’s Epidemic Intelligence Service Conference for more information.
URL:https://globalbiodefense.com/event/eis-2019-cdc-epidemic-intelligence-service-conference/
LOCATION:Sheraton Atlanta Hotel\, 165 Courtland St NE\, Atlanta\, GA\, 30303\, United States
CATEGORIES:Conference,Continuing Education
ATTACH;FMTTYPE=image/png:https://globalbiodefense.com/wp-content/uploads/2019/02/eis-2019-promote-1200x675.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190429
DTEND;VALUE=DATE:20190504
DTSTAMP:20181230T234541Z
CREATED:20180901T204535Z
LAST-MODIFIED:20181230T234541Z
UID:17153-1556496000-1556927999@globalbiodefense.com
SUMMARY:Aberdeen Proving Ground Discovery Week APBI
DESCRIPTION:Save the Date: Team Aberdeen Proving Ground (APG) anticipates hosting the APG Discovery Week Advanced Planning Briefing to Industry (APBI) the week of 29 April-3 May 2019\, at APG\, Maryland. \nAPG is home to more than 70 tenant organizations\, including: \n\nJoint Program Executive Office for Chemical Biological Defense (JPEO-CBD)\nUS Army Research Lab (ARL)\nUS Army Edgewood Chemical Biological Center (ECBC)\n20th Support Command (CBRNE)\nUS Army Test and Evaluation Command (ATEC)\nAberdeen Test Center (ATC)\nUS Army Medical Research Institute of Chemical Defense (USAMRICD)\nUS Army Research\, Development and Engineering Command (RDECOM)\nUS Army Public Health Command (USAPHC)\n\nThe goal of the APG Discovery Week APBI is to provide industry with networking opportunities for both large and small businesses. The APBI will describe potential future contracting opportunities for mission areas that focus on: \n\nCommand\, Control\, Communications\, Computers\, Intelligence\, Surveillance\, and Reconnaissance\nResearch and Development\nTest and Evaluation\nChemical and Biological Defense\nAPG Garrison\n\nThe APG Discovery Week APBI will identify potential contracting opportunities that are aligned with the roadmaps of each respective organization\, specifically focusing on Fiscal Years 2020-2021. Face-to-face breakout sessions between industry attendees and Government contracting representatives are available. \nThe APG Discovery Week APBI will be unclassified and open to all interested contractors\, large and small businesses\, and academia as well as other Government stakeholders. All attendees must be United States citizens. \nSpecific registration procedures and additional information about the APG Discovery Week APBI will be released via amendments on FedBizOps prior to registration opening.
URL:https://globalbiodefense.com/event/aberdeen-proving-ground-discovery-week-apbi/
LOCATION:Aberdeen Proving Ground\, 6000 Combat Drive\, Aberdeen Proving Ground\, MD\, 21005\, United States
ATTACH;FMTTYPE=image/png:https://globalbiodefense.com/wp-content/uploads/2018/09/aberdeen-proving-ground-discovery-week-2019.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190503
DTEND;VALUE=DATE:20190504
DTSTAMP:20190429T042725Z
CREATED:20190402T041450Z
LAST-MODIFIED:20190429T042725Z
UID:27085-1556841600-1556927999@globalbiodefense.com
SUMMARY:Eureka Prize for Infectious Diseases Research
DESCRIPTION:Entries are being accepted for the Eureka Prize for Infectious Diseases Research through 3 May 2019. \nActivity entered for this prize must have been undertaken in Australia or its territories (as defined by the Australian Government). \nFor a team entry\, the team leader must be either a) an Australian citizen\, b) an Australian permanent resident\, or c) a New Zealand citizen who was resident in Australia\, at the time the research entered was undertaken. \nSponsored by the Australian Infectious Diseases Research Centre\, the $10\,000 prize is awarded to an individual\, group or team for an outstanding recent contribution to infectious diseases research. \nActivity entered for this prize must have been undertaken as a single body of focused infectious diseases research in the past 7 years and have been published in one or more internationally respected scientific journals\, books or equivalent electronic publications. \nPlease visit the Eureka Prize for Infectious Diseases Research website for more information.
URL:https://globalbiodefense.com/event/eureka-prize-for-infectious-diseases-research/
LOCATION:Global Biodefense Calendar
CATEGORIES:Deadlines
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2019/04/biodefense-health-security-opportunity-deadline.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190505
DTEND;VALUE=DATE:20190509
DTSTAMP:20190501T165214Z
CREATED:20190213T173315Z
LAST-MODIFIED:20190501T165214Z
UID:23465-1557014400-1557359999@globalbiodefense.com
SUMMARY:ASM Clinical Virology Symposium 2019
DESCRIPTION:Hear the latest on microbiome-virome interactions\, RNA sequencing for viral diagnosis\, the challenges and opportunities for a universal influenza vaccine\, and more at the 2019 ASM Clinical Virology Symposium\, May 5-8\, 2019. \nWith presentations on the latest research in the field\, you won’t want to miss your chance to hear from top biomedical scientists\, physicians\, and laboratorians about the findings that will shape the future of clinical virology. \nIn addition\, the Pan American Society for Clinical Virology (PASCV) will host the Molecular Virology Workshop\, May 4\, 2019. \nHighlighted topics and presentations include: \n\nOne Health: Challenges of Zoonotic Infections; Jennifer McQuiston; CDC\nHot Topics in Virology; Emily A. Blumberg; Perelman Sch. of Med. at the Univ. of Pennsylvania\nCRISPR-Cas Biology and Infectious Diseases Diagnostic Applications; Daniel S. Chertow; NIH\nDevelopment and Use of Molecular Diagnostic Assays During Recent Ebola and Lassa Fever Outbreaks; Trevor Shoemaker; CDC\nLaboratory Diagnosis of Viral Disease; John Watson; Centers for Disease Control and Prevention\nTest and Treat Diagnostics; Devasena Gnanashanmugam; Cepheid\nEvaluation of Laboratory Contamination during Routine Testing of Infectious Specimens; Melanie Yarbrough; Washington Univ. Sch. of Med.\nA Quick Primer: The Spectrum of Point-of-Care Molecular Tests; Richard Hodinka; Univ. of South Carolina Sch. of Med.\nCirculating EBV and KSHV DNA for Diagnosis and Monitoring; Richard Ambinder; Johns Hopkins Sch. of Med.\nntegration of Point-of-Care Molecular Diagnostics in the Hospital Setting; Frederick Nolte; Med. Univ. of South Carolina\nIs It Time for Point-of-Care Molecular Diagnostics in Pharmacies?; Donald Klepser; Univ. of Nebraska Med. Ctr.\nIntegrative Network Modeling Reveals Host-Pathogen in Alzheimer’s Disease\nHepatitis A Outbreaks on the Rise Across the U.S.; Monique A. Foster; CDC\n\nPlease visit ASM’s Clinical Virology Symposium website for more information
URL:https://globalbiodefense.com/event/2019-asm-clinical-virology-symposium/
LOCATION:Savannah International Trade and Convention Center\, 1 International Drive \, Savannah\, GA\, 31402\, United States
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190506
DTEND;VALUE=DATE:20190507
DTSTAMP:20190429T045256Z
CREATED:20190407T023001Z
LAST-MODIFIED:20190429T045256Z
UID:25856-1557100800-1557187199@globalbiodefense.com
SUMMARY:National Network of Libraries of Medicine Wikipedia Edit-a-Thon
DESCRIPTION:The National Network of Libraries of Medicine (NNLM) is continuing its efforts to improve consumer health information on Wikipedia with its third Edit-a-Thon on May 6\, 2019. \nUsing trusted National Library of Medicine resources like PubMed\, MedlinePlus\, and Genetics Home Reference\, NNLM will be working to add citations to existing Wikipedia articles related to health equity. \nCheck out nnlm.gov/wiki to learn more about the event and make sure to follow along on Twitter throughout the day with the hashtag #citeNLM to ask questions\, post photos\, and share your Wikipedia experience. See you on May 6! \nEditor’s note: Please follow their lead and lend your expertise in Infectious Diseases to improve Wikipedia entries.
URL:https://globalbiodefense.com/event/nnlm-spring-2019-wikipedia-edit-a-thon/
LOCATION:Online
CATEGORIES:Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190506
DTEND;VALUE=DATE:20190507
DTSTAMP:20190501T162802Z
CREATED:20190422T050330Z
LAST-MODIFIED:20190501T162802Z
UID:26437-1557100800-1557187199@globalbiodefense.com
SUMMARY:Integration of Opioid and Infectious Disease Prevention Efforts in Select Programs
DESCRIPTION:The National Academies Health and Medicine Division will host a public meeting of the Committee on Examination of the Integration of Opioid and Infectious Disease Prevention Efforts in Select Programs on 7 May 2019. \nThe workshop will take place in Washington D.C. \nThe committee will hear from invited speakers regarding topics pertaining to the statement of task. \nPrimary session topics include: \n\nMulti-site HIV Program with Integrated Opioid Treatment\nComprehensive Treatment of Substance Abuse and Infectious Disease\nIntegration of Hepatitis C Virus Treatment and Substance Abuse Treatment via Telemedicine\nIntegrated Substance Use Treatment and Infectious Disease Treatment Programs (Inpatient / Outpatient)\n\nThe committee was charged with assessing the extent to which opioid and infectious disease prevention programs are integrating the services they provide. The committee will identify and highlight programs that are achieving integration as well as barriers to integration. Conclusions and recommendations from the committee will inform projects that promote patient-centered\, integrated programs to address the opioid and infectious disease epidemics. \nPlease visit the NASEM website for more information.
URL:https://globalbiodefense.com/event/opioid-infectious-disease-prevention-efforts/
LOCATION:National Academy of Sciences\, 2101 Constitution Avenue Northwest\, Washington\, DC\, 20418\, United States
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190508
DTEND;VALUE=DATE:20190512
DTSTAMP:20190501T170200Z
CREATED:20190216T054737Z
LAST-MODIFIED:20190501T170200Z
UID:23606-1557273600-1557619199@globalbiodefense.com
SUMMARY:MAD-ID 2019: Making a Difference in Infectious Diseases
DESCRIPTION:The 22nd Annual MAD-ID Meeting will be held in Orlando\, Florida\, May 8-11\, 2019. \nPharmacists physicians\, nurses and other providers will be given the opportunity to participate in a 3-day educational symposium specifically designed to apply recent research to patient care and antimicrobial stewardship. \nHighlighted sessions include: \n\nThe AMR Challenge: How to Meet the Challenge at Your Institutions\nNew Tests and Technologies for the Microbiology Steward\nPoint of Care Diagnostic Testing\, the Next Frontier for ASPs\nNew Gram-Negative Agents\, Gram-Positive Agents\nOptimizing therapy for Gram-Negative Bacteremia\nShort Course Therapy for Common Infections\nThe Expanding the Antibiotic Pipeline\nBehavior Change Interventions to Improve Outcomes\nPractical Interventions with the Micro Lab\nFormulary Management Strategies in Antimicrobial Stewardship\n\nMAD-ID is an approved provider of continuing pharmacy education and automatically reports to the National Association of Boards of Pharmacy via CPE Monitor.
URL:https://globalbiodefense.com/event/mad-id-2019-making-a-difference-in-infectious-diseases/
LOCATION:Rosen Centre Hotel\, 9840 International Drive\, Orlando\, FL\, 32819\, United States
CATEGORIES:Conference,Continuing Education
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190514
DTEND;VALUE=DATE:20190515
DTSTAMP:20190501T171155Z
CREATED:20190407T063506Z
LAST-MODIFIED:20190501T171155Z
UID:25860-1557792000-1557878399@globalbiodefense.com
SUMMARY:3rd Annual NPC Pandemic and Biosecurity Forum
DESCRIPTION:The Scowcroft Institute of International Affairs at the Bush School of Government and Public Service presents the Third Annual Pandemic & Biosecurity Policy Summit on 14 May 2019 at the National Press Club in Washington\, D.C. \nThe discussion will address the 100th anniversary of the 1918-19 influenza outbreak and consider global health security challenges of the 21st Century. \nThis event is designed to foster strategic dialogue with influential thought leaders\, senior U.S. and host country government officials\, and pandemic and biosecurity experts about the growing challenges faced by the international community and policy recommendations for strengthening preparedness and response.
URL:https://globalbiodefense.com/event/3rd-annual-npc-pandemic-and-biosecurity-forum/
LOCATION:National Press Club\, 529 14th Street NW\, Washington\, DC\, 20045\, United States
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190515
DTEND;VALUE=DATE:20190517
DTSTAMP:20190429T043814Z
CREATED:20190406T012129Z
LAST-MODIFIED:20190429T043814Z
UID:25842-1557878400-1558051199@globalbiodefense.com
SUMMARY:NIAID Small Business Workshop - Los Angeles
DESCRIPTION:The National Institute of Allergy and Infectious Diseases (NIAID) SBIR/STTR Small Business Workshop 2019 will take place 15-16 May 2019 in Los Angeles\, California. \nBiotechnology entrepreneurs\, faculty members\, postdoctoral fellows\, and interested innovators starting a new enterprise can learn about NIH-supported entrepreneurship opportunities\, writing successful grant applications\, and NIH SBIR/STTR policies and regulations. \nThe purpose of this workshop is to prepare current and next-generation biomedical entrepreneurs to compete in NIAID’s (and other Federal) SBIR/STTR programs\, and survey other resources for technology commercialization. Attendees will learn about career opportunities in biomedical entrepreneurship that are supported by the NIH\, receive guidance for preparation of successful grant applications\, and be updated on current NIH SBIR/STTR policies and regulations. We will also discuss SBIR/STTR opportunities for women-owned and socially and economically disadvantaged small businesses. \nThe agenda will include: an overview of the NIH SBIR/STTR programs\, introductions to programs administered by NIAID\, application review\, award management\, Venture Capital and other sources of Investment\, SBIR/STTR grant/proposal writing\, panel discussions\, and one-on-one sessions with NIH Staff.
URL:https://globalbiodefense.com/event/niaid-small-business-workshop-los-angeles/
LOCATION:California NanoSystems Institute at UCLA\, 570 Westwood Plaza\, Los Angeles\, 90095\, United States
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190515T190000
DTEND;TZID=America/New_York:20190515T200000
DTSTAMP:20190501T172329Z
CREATED:20190317T231744Z
LAST-MODIFIED:20190501T172329Z
UID:25407-1557946800-1557950400@globalbiodefense.com
SUMMARY:Emerging Infectious Diseases of Wildlife: A Biosecurity Threat
DESCRIPTION:A ChABSA Technical Seminar will be held in Gaithersburg MD and by webcast on 15 May 2019 on Emerging Infectious Diseases of Wildlife: A Biosecurity Threat. \nSpeaker Bio \nDr. Karen Lips\, Professor of Biology at the University of Maryland is the presenter. She has a B.S. in Zoology from the University of South Florida\, and a Ph.D. in Biology from the University of Miami. She is a field ecologist who studies how global change affects biodiversity. She is interested in how the loss of biodiversity affects communities and ecosystems\, and how human activities contribute to the spread of disease and loss of biodiversity. Dr. Lips was a Jefferson Science Fellow at the Department of State\, where she worked in the Bureau of Western Hemisphere Affairs\, in the Office of Public Diplomacy and Public Affairs\, and where she served as an Embassy Science Fellow in Colombia. Dr. Lips is a Research Associate at the US Museum of Natural History\, an AAAS Leshner Leadership Public Engagement Fellow\, an AAAS Fellow\, an ESA Fellow\, and an Aldo Leopold Leadership Fellow. She was awarded the President’s Award of the Chicago Zoological Society\, a Bay and Paul Biodiversity Leadership Award\, the Sabin Amphibian Conservation Award in 2012\, and the inaugural UMD Impact Communicator Award. Dr. Lips is interested in increasing engagement on environmental issues\, promoting scientific leadership\, and fostering international scientific collaborations.
URL:https://globalbiodefense.com/event/emerging-infectious-diseases-of-wildlife-a-biosecurity-threat/
LOCATION:Medimmune\, One Medimmune Way\, Gaithersburg\, MD\, 20878\, United States
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190517
DTEND;VALUE=DATE:20190518
DTSTAMP:20190513T160228Z
CREATED:20190504T154020Z
LAST-MODIFIED:20190513T160228Z
UID:27240-1558051200-1558137599@globalbiodefense.com
SUMMARY:DARPA ReVector Proposers Day
DESCRIPTION:The Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office is holding a Proposers Day meeting on 17 May 2019 to provide information to potential proposers on the objectives of the new ReVector program and to facilitate teaming. \nThe goal of ReVector is to develop an easily delivered treatment — for example\, a topical solution — that safely and temporarily modifies the human skin microbiome to alter scents and thereby reduce attraction of disease-spreading mosquitoes. \nThe Proposers Day will include overview presentations by DARPA personnel and potential government partners; an information session during which government personnel will respond to questions posed by participants; “lightning” talks (three minutes\, one slide) to allow potential proposers to highlight technical capabilities of interest and promote teaming; and short sidebars with DARPA personnel for discussion of any proprietary information that participants would not want to disclose in the other open sessions. \nAttendance at this event is not a requirement for submission of a proposal or selection for funding. Information relayed during the Proposers Day will be made available on the BTO section of the DARPA Opportunities page: http://www.darpa.mil/work-with-us/opportunities. \nDue to space limitations\, attendance is limited to no more than three attendees per division/department unless capacity is not reached. \nParticipants must register in advance through the registration website. You will be required to show government-issued\, picture identification that is compliant with the REAL ID Act of 2005. \nInformation about registration and various other meeting details can be found at the registration website. \nFurther administrative questions should be addressed to DARPA-SN-19-48@darpa.mil. Please refer to the ReVector Proposers Day (DARPA-SN-19-48) in all correspondence. \nDARPA hosts Proposers Days to provide potential performers with information on whether and how they might respond to the Government’s research and development solicitations and to increase efficiency in proposal preparation and evaluation. Therefore\, the ReVector Proposers Day is open only to registered potential applicants\, and not to the media or general public.
URL:https://globalbiodefense.com/event/darpa-revector-proposers-day/
LOCATION:Executive Conference Center (ECC)\, 4075 Wilson Boulevard\, Arlington\, VA\, 22203\, United States
CATEGORIES:Conference,Industry Day
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2019/05/darpa-bto-revector-proposers-day.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190520
DTEND;VALUE=DATE:20190521
DTSTAMP:20190421T201832Z
CREATED:20190421T201149Z
LAST-MODIFIED:20190421T201832Z
UID:26412-1558310400-1558396799@globalbiodefense.com
SUMMARY:RFI Deadline - Malaria Prophylactic Drug Tafenoquine
DESCRIPTION:The U.S. Army Medical Research Acquisition Activity (USAMRAA) located at FT. Detrick\, MD\, has issued a solicitation outlining plans to conduct User Acceptance Testing for the malaria prophylactic drug (Tafenoquine) brand name Arakoda. \nThe operational testing will look at the drug’s performance attributes and usability. \nThe DoD is seeking sources\, capability statements\, and industry feedback for this requirement for one commercial lot of ~120\,000 tablets (7\,500 packages) of Tafenoquine brand name Arakoda immediately\, with base Contract Line Item Number (CLIN) and three optional CLINs to procure up to 3\,750 packages per CLIN. \nEntities interested in submitting a response must furnish in writing\, a 2-3 page (not including cover page\, index or list of references) synopsis of their capability to provide the described product\, including any necessary lead time. \nResponses are due Monday\, 20 May 2019\, 3:00 PM EST. \nRead the full article on the Malaria Drug RFI here.
URL:https://globalbiodefense.com/event/rfi-deadline-malaria-prophylactic-drug-tafenoquine/
LOCATION:Global Biodefense Calendar
CATEGORIES:Deadlines
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2019/04/global-biodefense-events-calendar-7.jpg
END:VEVENT
END:VCALENDAR